[HTML][HTML] Comparison of 68Ga-HBED-CC PSMA-PET/CT and multiparametric MRI for gross tumour volume detection in patients with primary prostate cancer based on …

C Zamboglou, V Drendel, CA Jilg, HC Rischke… - Theranostics, 2017 - ncbi.nlm.nih.gov
Purpose: The exact detection and delineation of the intraprostatic tumour burden is crucial
for treatment planning in primary prostate cancer (PCa). We compared 68 Ga-HBED-CC …

What medical, urologic, and radiation oncologists want from molecular imaging of prostate cancer

LK Ballas, AL de Castro Abreu… - Journal of Nuclear …, 2016 - Soc Nuclear Med
As molecular imaging better delineates the state of prostate cancer, clinical management
will evolve. The currently licensed imaging modalities are limited by lack of specificity or …

The delineation of intraprostatic boost regions for radiotherapy using multimodality imaging

AU Pathmanathan, EJ Alexander, RA Huddart… - Future …, 2016 - Taylor & Francis
Dose escalation to the prostate improves tumor control but at the expense of increased
rectal toxicity. Modern imaging can be used to detect the most common site of recurrence …

Diagnostic efficiency of hybrid imaging using PSMA ligands, PET/CT, PET/MRI and MRI in identifying malignant prostate lesions

S Scobioala, C Kittel, H Wolters, S Huss… - Annals of Nuclear …, 2021 - Springer
Objective The objective of this study was to assess the accuracy of 68 Ga-PSMA-11
PET/MRI, 18 F-PSMA-1007 PET/CT, 68 Ga-PSMA-11 PET/CT, and multiparametric (mp) MRI …

Isotropic expansion of the Intraprostatic gross tumor volume of primary prostate cancer patients defined in MRI—A correlation study with whole Mount …

M Kramer, SKB Spohn, S Kiefer, L Ceci, A Sigle… - Frontiers in …, 2020 - frontiersin.org
Introduction An accurate delineation of the intraprostatic gross tumor volume (GTV) is of
importance for focal treatment in patients with primary prostate cancer (PCa) …

Long-term Results of Hypofractionated Radiotherapy With Intra-prostatic Boosts in Men With Intermediate-and High-risk Prostate Cancer: A Phase II Trial

R Chatterjee, J Chan, H Mayles, S Cicconi, I Syndikus - Clinical Oncology, 2024 - Elsevier
Aims In the conventionally fractionated phase III FLAME prostate trial, focal boosts improved
local control and biochemical disease-free survival (bDFS). We explored the toxicity and …

Highly hypofractionated intensity-modulated radiation therapy for nonmetastatic prostate cancer with a simultaneous integrated boost to intraprostatic lesions: A …

R Ashida, K Nakamura, R Aizawa, H Iramina… - Japanese Journal of …, 2022 - Springer
Purpose The purpose of this planning study was to develop an acceptable technique for
highly hypofractionated intensity-modulated radiation therapy using simultaneous integrated …

Effect of androgen deprivation therapy on intraprostatic tumour volume identified on 18F choline PET/CT for prostate dose painting radiotherapy

J Chan, A Carver, JNH Brunt… - The British Journal of …, 2017 - academic.oup.com
Objective: Prostate dose painting radiotherapy requires the accurate identification of
dominant intraprostatic lesions (DILs) to be used as boost volumes; these can be identified …

Salvage prostate brachytherapy for postradiation local failure

G Créhange, IC Hsu, AJ Chang, M Roach - Management of Prostate …, 2017 - Springer
For a long time, one drawback of both prostate external-beam radiotherapy (EBRT) and
brachytherapy was linked to the risk of morbidity associated with any local salvage therapy …

[PDF][PDF] Cancers de la prostate

I Brenot-Rossi, PY Salaün - Médecine Nucléaire, 2019 - Elsevier
Une première recherche bibliographique a porté sur la TEP à la choline. La sélection
bibliographique a été réalisée sur la base de l'interrogation de la base de données …